Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer (original) (raw)

• Anderson, K.C. et al. T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. Blood 76, 235–244 (1990).
  Article CAS PubMed Google Scholar
• Guillaume, T., Rubinstein, D.B. & Symann, M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 92, 1471–1490 (1998).
  Article CAS PubMed Google Scholar
• Porrata, L.F. et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 98, 579–585 (2001).
  Article CAS PubMed Google Scholar
• Dhodapkar, M.V., Krasovsky, J. & Olson, K. T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells. Proc. Natl Acad. Sci. USA 99, 13009–13013 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Noonan, K. et al. Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. Cancer Res. 65, 2026–2034 (2005).
  Article CAS PubMed Google Scholar
• Li, L., Yee, C. & Beavo, J.A. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283, 848–851 (1999).
  Article CAS PubMed Google Scholar
• Boussiotis, V.A. et al. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6, 290–297 (2000).
  Article CAS PubMed Google Scholar
• Levine, B.L. et al. Adoptive Transfer of Costimulated CD4+ T cells Induces Expansion of Peripheral T Cells and Decreased CCR5 Expression in HIV Infection. Nat. Med. 8, 47–53 (2002).
  Article CAS PubMed Google Scholar
• Laport, G.G. et al. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood 102, 2004–2013 (2003).
  Article CAS PubMed Google Scholar
• Rapoport, A.P. et al. Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells. Bone Marrow Transplant. 33, 53–60 (2004).
  Article CAS PubMed Google Scholar
• Black, S. et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19, 187–195 (2000).
  Article CAS PubMed Google Scholar
• Gandhi, M.K. et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant. 28, 775–781 (2001).
  Article CAS PubMed Google Scholar
• Guinan, E.C. et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 57, 677–684 (1994).
  Article CAS PubMed Google Scholar
• Romero-Steiner, S. et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin. Infect. Dis. 29, 281–288 (1999).
  Article CAS PubMed Google Scholar
• Jokinen, J.T., Ahman, H., Kilpi, T.M., Makela, P.H. & Kayhty, M.H. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. J. Infect. Dis. 190, 545–550 (2004).
  Article CAS PubMed Google Scholar
• Jodar, L. et al. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21, 3265–3272 (2003).
  Article CAS PubMed Google Scholar
• Powers, D.C., Anderson, E.L., Lottenbach, K. & Mink, C.M. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J. Infect. Dis. 173, 1014–1018 (1996).
  Article CAS PubMed Google Scholar
• Shelly, M.A. et al. Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect. Immun. 65, 242–247 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Lottenbach, K.R. et al. Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. Infect. Immun. 67, 4935–4938 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Shelly, M.A., Pichichero, M.E. & Treanor, J.J. Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults. Scand. J. Infect. Dis. 33, 542–544 (2001).
  Article CAS PubMed Google Scholar
• Kamboj, K.K., Kirchner, H.L., Kimmel, R., Greenspan, N.S. & Schreiber, J.R. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. J. Infect. Dis. 187, 1629–1638 (2003).
  Article PubMed Google Scholar
• Hakim, F.T. et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 115, 930–939 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Uchida, T., Pappenheimer, A.M. Jr & Greany, R. Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. J. Biol. Chem. 248, 3838–3844 (1973).
  Article CAS PubMed Google Scholar
• Borrello, I. et al. Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood 95, 3011–3019 (2000).
  Article CAS PubMed Google Scholar
• Teshima, T. et al. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Res. 61, 162–171 (2001).
  CAS PubMed Google Scholar
• Overwijk, W.W. et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 198, 569–580 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Singhal, S. & Mehta, J. Reimmunization after blood or marrow stem cell transplantation. Bone Marrow Transplant. 23, 637–646 (1999).
  Article CAS PubMed Google Scholar
• Nordoy, T. et al. Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant. 28, 681–687 (2001).
  Article CAS PubMed Google Scholar
• Jones, R.J. et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1, 754–757 (1989).
  Article CAS PubMed Google Scholar
• Vavassori, M. et al. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients. J. Immunol. 157, 5739–5747 (1996).
  CAS PubMed Google Scholar
• Kirschner, D. & Panetta, J.C. Modeling immunotherapy of the tumor-immune interaction. J. Math. Biol. 37, 235–252 (1998).
  Article CAS PubMed Google Scholar
• Eaton, S.M., Burns, E.M., Kusser, K., Randall, T.D. & Haynes, L. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J. Exp. Med. 200, 1613–1622 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Molrine, D.C. et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 101, 831–836 (2003).
  Article CAS PubMed Google Scholar
• Antin, J.H. et al. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 11, 213–222 (2005).
  Article CAS PubMed Google Scholar
• Dummer, W. et al. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J. Clin. Invest. 110, 185–192 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Janssen, E.M. et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434, 88–93 (2005).
  Article CAS PubMed Google Scholar
• Heitger, A. et al. Defective T-helper cell function after T-cell-depleting therapy affecting naive and memory populations. Blood 99, 4053–4062 (2002).
  Article CAS PubMed Google Scholar
• Shinefield, H.R. et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr. Infect. Dis. J. 18, 757–763 (1999).
  Article CAS PubMed Google Scholar
• Eskola, J. et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344, 403–409 (2001).
  Article CAS PubMed Google Scholar
• de Aristegui, F.J. et al. Evaluation of the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar) administered in previously unvaccinated Spanish children aged 24 to 36 months. Vaccine 23, 1917–1922 (2005).
  Article CAS Google Scholar
• Ekstrom, N. et al. Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial. Infect. Immun. 73, 369–377 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Alexanian, R., Dimopoulos, M.A., Delasalle, K. & Barlogie, B. Primary dexamethasone treatment of multiple myeloma. Blood 80, 887–890 (1992).
  Article CAS PubMed Google Scholar
• Levine, B.L. et al. Effects of CD28 costimulation on long term proliferation of CD4+ T cells in the absence of exogenous feeder Cells. J. Immunol. 159, 5921–5930 (1997).
  CAS PubMed Google Scholar
• Concepcion, N.F. & Frasch, C.E. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 8, 266–272 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wells, A.D., Gudmundsdottir, H. & Turka, L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100, 3173–3183 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Novak, E.J., Liu, A.W., Nepom, G.T. & Kwok, W.W. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104, R63–R67 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Blade, J. et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br. J. Haematol. 102, 1115–1123 (1998).
  Article CAS PubMed Google Scholar